Skip to search formSkip to main contentSkip to account menu

iruxol

Known as: Collagenase, mixt. with (R-(R*,R*))-2,2-dichloro-N-(2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl)acetamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Background  It is well known that patients with chronic wounds frequently acquire clinically relevant contact sensitizations to… 
2007
2007
Deep dermal partial-thickness scalds remain one of the most common types of injuries in childhood. Local treatment of those… 
2006
2006
OBJECTIVE A large retrospective analysis was performed to assess the outcomes of burns and chronic ulcers treated with… 
2001
2001
Experience of clinical treatment of 9 patients with diabetes mellitus and diabetic angiopathy using alprostan in combination with… 
1998
1998
SummaryThe efficacy and tolerability of a new formulation of collagenase ointment (Iruxol® mono) was determined in a placebo… 
1993
1993
Analysis of the results of treatment of 150 alveolitis patients has demonstrated the advantages of the method using iruxol… 
1990
1990
  • E. Paul
  • Fortschritte der Medizin
  • 1990
  • Corpus ID: 1248201
In a multicenter study, a total of 100 wounds in 94 patients were treated with Iruxol ointment over a period of 3 weeks. The… 
1975
1975
A 18-year-old female patient complained of an irritating rash on the face. She thought she was sensitive to penicillin and to the…